In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Interest income: |
Interest income on loans | 478.9 | 431.9 | 252.2 | 227.0 | 230.0 | 233.9 | 232.8 | 227.4 |
Interest income on investments | 56.6 | 53.2 | 32.6 | 28.5 | 26.6 | 24.9 | 24.9 | 23.2 |
Interest income on repurchase agreements | 39.8 | 21.0 | 7.6 | 3.1 | 2.5 | 2.2 | 1.5 | 1.3 |
| 575.2 | 506.0 | 292.4 | 258.6 | 259.2 | 260.9 | 259.2 | 251.9 |
Interest expense: |
Interest on deposits | 228.7 | 176.6 | 18.2 | 10.3 | 10.6 | 12.1 | 13.9 | 17.5 |
| 259.8 | 193.8 | 27.8 | 19.1 | 20.4 | 23.3 | 26.0 | 29.0 |
Net interest income | 315.4 | 312.2 | 264.6 | 239.5 | 238.8 | 237.5 | 233.2 | 222.9 |
Provision for loan losses | 31.7 | 18.8 | 12.9 | 2.7 | 2.7 | 3.4 | 2.8 | 7.2 |
Net interest income after provision for loan losses | 283.7 | 293.5 | 251.7 | 236.8 | 236.1 | 234.2 | 230.4 | 215.6 |
Other non-interest income | 173.8 | 89.5 | 125.5 | 103.5 | 100.7 | 104.1 | 98.2 | 92.7 |
Total non-interest income | 173.8 | 89.5 | 125.5 | 103.5 | 100.7 | 104.1 | 98.2 | 92.7 |
Non-interest expenses | 211.6 | 211.7 | 196.0 | 182.7 | 170.4 | 168.9 | 166.1 | 154.7 |
Pre-tax income | 245.9 | 171.3 | 181.1 | 157.6 | 166.4 | 169.4 | 162.5 | 153.6 |
Income taxes | 48.6 | 34.0 | 36.0 | 28.5 | 32.9 | 32.8 | 30.7 | 28.2 |
Tax rate | 19.8% | 19.8% | 19.9% | 18.1% | 19.8% | 19.4% | 18.9% | 18.4% |
Net income | 193.5 | 133.5 | 141.3 | 125.3 | 129.7 | 132.8 | 128.0 | 121.6 |
Net margin | 42.3% | 34.8% | 37.5% | 36.8% | 38.5% | 39.3% | 39.0% | 39.4% |
|
Basic EPS | $2.55 | $1.76 | $1.87 | $1.66 | $1.72 | $1.76 | $1.70 | $1.61 |
Diluted EPS | $2.54 | $1.76 | $1.86 | $1.65 | $1.71 | $1.75 | $1.69 | $1.61 |
|
Shares outstanding (basic) | 76.0 | 75.9 | 75.8 | 75.7 | 75.5 | 75.5 | 75.5 | 75.4 |
Shares outstanding (diluted) | 76.1 | 76.0 | 75.9 | 75.9 | 75.9 | 75.8 | 75.8 | 75.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |